BSF ENTERPRISE PLC

AGM Information • Jul 12, 2022

National Storage Mechanism | Additional information

RNS Number : 1936S

BSF Enterprise PLC

12 July 2022

12 July 2022

BSF Enterprise plc

("BSF" or the "Company")

Results of Annual General Meeting

BSF Enterprise plc (LSE: BSFA),  is pleased to announce that at the Company's Annual General Meeting held earlier today, all resolutions proposed were duly passed by shareholders by way of a poll, the results of which were as follows:

Resolution		Poll Results
For	Against	Abstain	Discretionary	Total
1	Shares	43,864,905	-	-	-	‎43,864,905‎
%	100	-	-	-	100
2	Shares	‎43,864,905‎	-	-	-	‎‎43,864,905‎‎
%	100	-	-	-	100
3	Shares	‎43,864,905‎	-	-	-	‎‎43,864,905‎‎
%	100	-	-	-	100
4	Shares	‎43,864,905‎	-	-	-	‎‎43,864,905‎‎
%	100	-	-	-	100
5	Shares	‎‎43,864,905‎‎	-	-	-	‎‎43,864,905‎‎
	%	100	-	-	-	100
6	Shares	‎‎43,864,905‎‎	-	-	-	‎‎43,864,905‎‎
	%	100	-	-	-	100
7	Shares	‎‎43,864,905‎‎	-	-	-	‎‎43,864,905‎‎
	%	100	-	-	-	100

The total number of ordinary shares in issue on 12 July 2022 was ‎85,783,409‎‎ ‎ shares. Of the ordinary shares in issue, ‎7,798,491‎ shares have been issued as restricted shares under the Company's ‎Restricted Share Plan or under agreements containing equivalent terms, are subject to voting restrictions and ‎were restricted from being voted at the meeting.‎  56.25% of voting capital entitled to vote at the meeting was instructed in respect of the resolutions put to the Annual General Meeting.

The full text of the resolutions can be found in the Notice of Annual General Meeting dated 17 June 2022, which is ‎available on the Company's website at:‎ https://bsfenterprise.com/documents/  

In accordance with the FCA's Listing Rule 9.6.2, copies of all the ‎resolutions passed by the Company's shareholders, other than ordinary business will be ‎submitted to the National Storage Mechanism and will shortly be available for ‎inspection at

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further enquiries, please visit www.bsfenterprise.com or contact:

BSF Enterprise PLC	Via SEC Newgate below
Geoff Baker - Non-Executive Director Graham Duncan - Chief Financial Officer
Shard Capital (Broker)
Damon Heath Erik Woolgar	020 7186 9952
SEC Newgate (Financial Communications)
Bob Huxford Elisabeth Cowell George Esmond	020 3757 6882 BSF@secnewgate.co.uk

‎LEI: ‎‎2138007PJT69H8FYLC06‎

Notes to Editors

BSF Enterprise PLC (BSF) is focused on unlocking the next generation of biotechnological solutions - using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes, as part of a radical transformation to deliver sustainable solutions across a variety of sectors.

It owns 100% of 3D Bio Tissues (3DBT), a tissue engineering with patent-protected IP that is already producing human corneas to help restore vision to millions of people. Building on this success, it aims to produce the UK's first high quality lab-grown meat from its laboratory in Newcastle the next 12 months, transforming the meat-production industry towards an ethical and sustainable practice. 

BSF aims to deliver growth to shareholders through the continued commercialisation of 3DBT's IP, which has multiple applications, as well as through M&A. It aims to acquire a suite of technologies that underpins the development of tissue templating for corneas, meat and leather, and license out the IP to manufacturers, wholesalers and distributors to help manufacture the products at scale. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGUURARUUUBAAR